| Pharmaceutical Information |
| Drug Name |
Orphenadrine |
| Drug ID |
BADD_D01625 |
| Description |
A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. |
| Indications and Usage |
Indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB01173
|
| KEGG ID |
D08305
|
| MeSH ID |
D009966
|
| PubChem ID |
4601
|
| TTD Drug ID |
D0D9FV
|
| NDC Product Code |
Not Available |
| UNII |
AL805O9OG9
|
| Synonyms |
Orphenadrine | Methyldiphenylhydramine | Lysantin | Mefenamine | Mephenamine | Norflex | Orphenadrine Citrate | Citrate, Orphenadrine | Orphenadrine Hydrochloride | Hydrochloride, Orphenadrine | Sodium Mefenamine | Mefenamine, Sodium | Disipal | Norflex Orphenadrine Citrate | Citrate, Norflex Orphenadrine | Orphenadrine Citrate, Norflex |
|
| Chemical Information |
| Molecular Formula |
C18H23NO |
| CAS Registry Number |
83-98-7 |
| SMILES |
CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
